共 133 条
[1]
Tsao CW(2022)Heart disease and stroke statistics-2022 update: a report from the American heart association Circulation 145 e153-e639
[2]
Aday AW(2017)Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study BMC Cardiovasc Disord 17 160-846
[3]
Almarzooq ZI(2020)PCSK9 inhibition: insights from clinical trials and future prospects Front Physiol 11 595819-290
[4]
Alonso A(2021)Guideline-driven management of hypertension: an evidence-based update Circ Res 128 827-317
[5]
Beaton AZ(2017)Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the american college of physicians Ann Intern Med 166 279-e50
[6]
Bittencourt MS(2023)2022 ACC expert consensus decision pathway for integrating atherosclerotic cardiovascular disease and multimorbidity treatment: a framework for pragmatic, patient-centered care: a report of the american college of cardiology solution set oversight committee J Am Coll Cardiol 81 292-6
[7]
Halcox JP(2020)Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study Lancet Public Health 5 e42-9
[8]
Banegas JR(2021)Association of in-hospital multimorbidity with healthcare outcomes in Swiss medical inpatients Swiss Med Wkly 151 w20405-226
[9]
Roy C(2022)Multimorbidity Nat Rev Dis Primers 8 48-45
[10]
Katzmann JL(2014)AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services J Am Coll Cardiol. 64 1851-3188